IOCAS-IR  > 海洋生物技术研发中心
Fucoidan protects against dopaminergic neuron death in vivo and in vitro
Luo, Dingzhen1; Zhang, Quanbin2; Wang, Haomin3; Cui, Yanqiu1; Sun, Zuoli1; Yang, Jian1; Zheng, Yan1; Jia, Jun1; Yu, Fen1; Wang, Xuan1; Wang, Xiaomin1
2009-09-01
发表期刊EUROPEAN JOURNAL OF PHARMACOLOGY
ISSN0014-2999
卷号617期号:1-3页码:33-40
文章类型Article
摘要Parkinson's disease is a neurodegenerative disorder of uncertain pathogenesis characterized by a loss of dopaminergic neurons in substantia nigra pars compacta, and can be modeled by the neurotoxin 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP). Oxidative stress may contribute to MPTP- and Parkinson's disease-related neurodegeneration. Fucoidan is a sulfated polysaccharide extracted from brown seaweeds which possesses a wide variety of biological activities including potent antioxidative effects. Here we investigated the effect of fucoidan treatment on locomoter activities of animals, striatal dopamine and its metabolites and survival of nigral dopaminergic neurons in MPTP-induced animal model of Parkinsonism in C57/BL mice in vivo and on the neuronal damage induced by 1-methyl-4-phenylpyridinium (MPP(+)) in vitro, and to study the possible mechanisms. When administered prior to MPTP, fucoidan reduced behavioral deficits, increased striatal dopamine and its metabolites levels, reduced cell death, and led to a marked increase in tyrosine hydroxylase expression relative to mice treated with MPTP alone. Furthermore, we found that fucoidan inhibited MPTP-induced lipid peroxidation and reduction of antioxidant enzyme activity. In addition, pre-treatment with fucoidan significantly protected against MPP(+)-induced damage in MN9D cells. Taken together, these findings suggest that fucoidan has protective effect in MPTP-induced neurotoxicity in this model of Parkinson's disease via its antioxidative activity. (C) 2009 Elsevier B.V. All rights reserved.; Parkinson's disease is a neurodegenerative disorder of uncertain pathogenesis characterized by a loss of dopaminergic neurons in substantia nigra pars compacta, and can be modeled by the neurotoxin 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP). Oxidative stress may contribute to MPTP- and Parkinson's disease-related neurodegeneration. Fucoidan is a sulfated polysaccharide extracted from brown seaweeds which possesses a wide variety of biological activities including potent antioxidative effects. Here we investigated the effect of fucoidan treatment on locomoter activities of animals, striatal dopamine and its metabolites and survival of nigral dopaminergic neurons in MPTP-induced animal model of Parkinsonism in C57/BL mice in vivo and on the neuronal damage induced by 1-methyl-4-phenylpyridinium (MPP+) in vitro, and to study the possible mechanisms. When administered prior to MPTP, fucoidan reduced behavioral deficits, increased striatal dopamine and its metabolites levels, reduced cell death, and led to a marked increase in tyrosine hydroxylase expression relative to mice treated with MPTP alone. Furthermore, we found that fucoidan inhibited MPTP-induced lipid peroxidation and reduction of antioxidant enzyme activity. In addition, pre-treatment with fucoidan significantly protected against MPP+-induced damage in MN9D cells. Taken together, these findings suggest that fucoidan has protective effect in MPTP-induced neurotoxicity in this model of Parkinson's disease via its antioxidative activity. (C) 2009 Elsevier B.V. All rights reserved.
关键词Fucoidan Neuroprotection Antioxidant Activity Oxidative Stress Parkinson's Disease 1-methyl-4-phenyl-1 2 3 6-tetrahydropyridine
学科领域Pharmacology & Pharmacy
DOI10.1016/j.ejphar.2009.06.015
URL查看原文
收录类别SCI
语种英语
WOS记录号WOS:000269867400006
引用统计
被引频次:100[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.qdio.ac.cn/handle/337002/3476
专题海洋生物技术研发中心
作者单位1.Capital Med Univ, Minist Educ, Key Lab Neurodegenerat Dis, Beijing 100069, Peoples R China
2.Chinese Acad Sci, Inst Oceanol, Qingdao 266071, Peoples R China
3.Peking Univ, Neurosci Res Inst, Beijing 100083, Peoples R China
推荐引用方式
GB/T 7714
Luo, Dingzhen,Zhang, Quanbin,Wang, Haomin,et al. Fucoidan protects against dopaminergic neuron death in vivo and in vitro[J]. EUROPEAN JOURNAL OF PHARMACOLOGY,2009,617(1-3):33-40.
APA Luo, Dingzhen.,Zhang, Quanbin.,Wang, Haomin.,Cui, Yanqiu.,Sun, Zuoli.,...&Wang, Xiaomin.(2009).Fucoidan protects against dopaminergic neuron death in vivo and in vitro.EUROPEAN JOURNAL OF PHARMACOLOGY,617(1-3),33-40.
MLA Luo, Dingzhen,et al."Fucoidan protects against dopaminergic neuron death in vivo and in vitro".EUROPEAN JOURNAL OF PHARMACOLOGY 617.1-3(2009):33-40.
条目包含的文件
文件名称/大小 文献类型 版本类型 开放类型 使用许可
luo-Fucoidan protect(1140KB) 限制开放--浏览
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Luo, Dingzhen]的文章
[Zhang, Quanbin]的文章
[Wang, Haomin]的文章
百度学术
百度学术中相似的文章
[Luo, Dingzhen]的文章
[Zhang, Quanbin]的文章
[Wang, Haomin]的文章
必应学术
必应学术中相似的文章
[Luo, Dingzhen]的文章
[Zhang, Quanbin]的文章
[Wang, Haomin]的文章
相关权益政策
暂无数据
收藏/分享
文件名: luo-Fucoidan protects against dopaminergic neuron.pdf
格式: Adobe PDF
此文件暂不支持浏览
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。